Related Experiment Video
Updated: Jul 3, 2026

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
[The efficacy of probiotics in gastrointestinal disease]
Takeshi Kamiya1, Michiko Shikano, Tsuneya Wada
1Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences.
Abstract:
Probiotics are live microbial feed supplement which beneficially affects the host animals by improving its microbial balance. Probiotics have been used in the treatment of bacterial or viral induced acute intestinal infection. In recent years, some clinical studies have shown the therapeutic effects of probiotics in the treatment of chronic inflammatory bowel disease (IBD) or prevention of allergic disease. Evidence exists for therapeutic use of probiotics in acute infectious diarrhea, Clostridium difficile colitis and antibiotic-associated diarrhea. Their exact role in IBD, irritable bowel syndrome and prevention of cancer has not to be determined. This review summarized the data about probiotics in gastrointestinal diseases and examine the mechanisms of action related to their therapeutic effects.
Related Concept Videos
Probiotics
Microbiota Modulation by Antibiotics
Dysbiosis of the Gut Microbiota
Functions of the Gut Microbiota
Microbiota of the Stomach and Small Intestine
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
